News & Analysis on Clinical Trial Services & Contract Research And Development
People on the Move
By Melissa Fassbender
- Last updated on
Bioclinica has named David Herron as the company’s next CEO, effective January 2, 2018. Herron’s promotion follows 10 years with the company and more than 25 years in healthcare technology.
“What I hope to achieve as Bioclinica CEO is to lead the company to achieve its full potential by leveraging our unique combination of scientific, medical and regulatory expertise with superior technology," Herron told us.
"Bioclinica will become the global leader of transformative and value-enhanced solutions within the highly complex and ever-evolving regulatory environment.”
Upon his planned retirement, the current CEO, John Hubbard, PhD, will remain as a non-executive director on the Bioclinica Board.